Upgrade to SI Premium - Free Trial

Evaxion Biotech (EVAX)

3.55 -0.32 (8.27%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26 *Est.)

Latest Headlines

Form 6-K Evaxion A/S For: May 12 May 12, 2026 9:30 AM - SEC Filing Evaxion to present EVX-04 leukemia vaccine data at EHA 2026 Congress May 12, 2026 9:30 AM - StreetInsider Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress May 12, 2026 9:30 AM - StreetInsider Evaxion Biotech (EVAX) Misses Q1 EPS by 1c May 7, 2026 8:06 AM - StreetInsider Form 6-K Evaxion A/S For: May 07 May 7, 2026 7:40 AM - SEC Filing Evaxion announces business update and first quarter 2026 financial results May 7, 2026 7:30 AM - Globe NewsWire Form 6-K Evaxion A/S For: May 04 May 4, 2026 8:08 AM - SEC Filing Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026 May 4, 2026 8:00 AM - StreetInsider Form 6-K Evaxion A/S For: Apr 27 April 27, 2026 8:10 AM - SEC Filing Evaxion promotes Birgitte Rønø to dual CSO and COO role April 27, 2026 8:00 AM - StreetInsider Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer April 27, 2026 8:00 AM - Globe NewsWire Form 3 Evaxion A/S For: Apr 16 Filed by: Bitsch-Norhave Jens April 24, 2026 5:20 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Evaxion Biotech (EVAX) April 24, 2026 6:44 AM - StreetInsider Form 6-K Evaxion A/S For: Apr 21 April 22, 2026 7:01 AM - SEC Filing Form 6-K Evaxion A/S For: Apr 17 April 17, 2026 3:30 PM - SEC Filing Form 6-K Evaxion A/S For: Apr 17 April 17, 2026 3:20 PM - SEC Filing Evaxion reports 86% precision rate for AI cancer vaccine platform April 17, 2026 3:10 PM - StreetInsider Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial April 17, 2026 3:10 PM - StreetInsider Evaxion presents glioblastoma vaccine data at cancer research meeting April 17, 2026 3:00 PM - StreetInsider New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma April 17, 2026 3:00 PM - StreetInsider Form 6-K Evaxion A/S For: Apr 16 April 16, 2026 12:01 PM - SEC Filing Evaxion concludes Annual General Meeting April 16, 2026 11:30 AM - StreetInsider Form 3/A Evaxion A/S For: Mar 18 Filed by: Mattsson Andreas Holm April 10, 2026 4:21 PM - SEC Filing Form 6-K Evaxion A/S For: Apr 07 April 7, 2026 12:48 PM - SEC Filing Evaxion completes phase 2 trial extension for cancer vaccine EVX-01 April 7, 2026 12:34 PM - StreetInsider Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01 April 7, 2026 12:34 PM - Globe NewsWire Evaxion completes phase 2 trial extension for personalized cancer vaccine April 7, 2026 8:14 AM - StreetInsider Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01 April 7, 2026 8:14 AM - StreetInsider Evaxion completes phase 2 cancer vaccine trial extension April 7, 2026 8:13 AM - StreetInsider Form 3/A Evaxion A/S For: Mar 18 Filed by: Soegaard Marianne April 2, 2026 4:08 PM - SEC Filing Form 3/A Evaxion A/S For: Mar 18 Filed by: Wegner Lars Aage Staal April 1, 2026 8:56 PM - SEC Filing Form 3/A Evaxion A/S For: Mar 18 Filed by: TAYTON-MARTIN HELEN KATRINA March 31, 2026 7:23 PM - SEC Filing Form 6-K Evaxion A/S For: Mar 30 March 30, 2026 8:05 AM - SEC Filing Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress March 30, 2026 8:00 AM - StreetInsider Form 3/A Evaxion A/S For: Mar 18 Filed by: Rono Birgitte March 27, 2026 5:10 PM - SEC Filing Form 3/A Evaxion A/S For: Mar 18 Filed by: Schmidt Thomas Frederik March 27, 2026 5:10 PM - SEC Filing Form 3/A Evaxion A/S For: Mar 18 Filed by: Prego Roberto March 27, 2026 5:09 PM - SEC Filing Form 6-K Evaxion A/S For: Mar 19 March 19, 2026 9:10 AM - SEC Filing Notice to convene Evaxion’s Annual General Meeting March 19, 2026 9:01 AM - Globe NewsWire Form 6-K Evaxion A/S For: Mar 19 March 19, 2026 9:00 AM - SEC Filing Notice to convene Evaxion’s Annual General Meeting March 19, 2026 9:00 AM - StreetInsider Form 3 Evaxion A/S For: Mar 18 Filed by: Evaxion A/S March 18, 2026 9:13 PM - SEC Filing Form 3 Evaxion A/S For: Mar 18 Filed by: Evaxion A/S March 18, 2026 9:12 PM - SEC Filing Form 3 Evaxion A/S For: Mar 18 Filed by: Evaxion A/S March 18, 2026 9:11 PM - SEC Filing Form 3 Evaxion A/S For: Mar 18 Filed by: Evaxion A/S March 18, 2026 9:10 PM - SEC Filing Form 3 Evaxion A/S For: Mar 18 Filed by: Evaxion A/S March 18, 2026 9:09 PM - SEC Filing Form 3 Evaxion A/S For: Mar 18 Filed by: Evaxion A/S March 18, 2026 9:08 PM - SEC Filing Form 3 Evaxion A/S For: Mar 18 Filed by: HOLTUG LARS March 18, 2026 9:07 PM - SEC Filing Form 3 Evaxion A/S For: Mar 18 Filed by: Evaxion A/S March 18, 2026 9:06 PM - SEC Filing Form 6-K Evaxion A/S For: Mar 17 March 17, 2026 4:40 PM - SEC Filing Evaxion to present cancer vaccine data at AACR meeting March 17, 2026 4:30 PM - StreetInsider Evaxion to present new data at AACR Annual Meeting March 17, 2026 4:30 PM - StreetInsider Evaxion Biotech (EVAX) PT Lowered to $9 at Lake Street March 9, 2026 8:41 AM - StreetInsider Full Article List